Vacuum erection device in treatment of organic erectile dysfunction and penile vascular differences between patients with DM type I and DM type II.
The aim of this study is to investigate changes in the vascular system and hemodynamics between patients with organic erectile dysfunction (ED) (DM type I and II), as well as to compare the quality of sexual life between those two groups after the treatment with vacuum erection device (VED). Study enrolled 50 males with DM, aged from 35 to 67 years, who have attended the urologic clinic due to inability to attain and maintain an erection of the penis sufficient to permit satisfactory sexual intercourse. Patients were using VED and six months later were assessed for therapy results. The International Index of Erectile Function (IIEF) was used to quantify erectile dysfunction. Alprostadil injection test was also used, with Doppler color flow imaging system, to evaluate the peak systolic velocity (PSV) and diameter of cavernosal artery (DCA). Significantly higher values of PSV were obtained in patients with DM type II. Also, DCA showed significant difference between two groups of patients. There was significant improvement in three items of IIEF after six months of treatment among both groups of examinees. Patients with DM type I had more serious risk for development of arteriogenic ED. VED could be a good alternative therapy for patients who denied peroral therapy.
a Faculty of Medicine , University of Montenegro , Podgorica , Montenegro.
Bogdan
B
Pajovic
b Urology Clinic, Clinical Centre of Kragujevac , Kragujevac , Serbia.
Antonio
A
Dimitrovski
c Department of Vascular Surgery , Clinical Centre of Montenegro , Podgorica , Montenegro , and.
Nikola
N
Fatic
d Urology and Nephrology Clinic, Clinical Centre of Montenegro , Podgorica , Montenegro.
Milos
M
Malidzan
d Urology and Nephrology Clinic, Clinical Centre of Montenegro , Podgorica , Montenegro.
Marko
M
Vukovic
D000328:Adult; D000368:Aged; D000527:Alprostadil / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D018783:Impotence, Vasculogenic / Q000209:etiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010413:Penis / Q000098:blood supply*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011446:Prospective Studies; D011788:Quality of Life; D012725:Sexual Behavior; D014618:Vacuum
D010726:Phosphodiesterase Inhibitors; D000527:Alprostadil
Erectile dysfunction; diabetes mellitus; vacuum erection device